UBS Group’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.3K | Sell |
34,324
-21,487
| -38% | -$42.8K | ﹤0.01% | 6257 |
|
|
2025
Q1 | $80.9K | Buy |
55,811
+9,308
| +20% | +$13.5K | ﹤0.01% | 5931 |
|
|
2024
Q4 | $96.3K | Buy |
46,503
+29,597
| +175% | +$61.3K | ﹤0.01% | 5684 |
|
|
2024
Q3 | $29.8K | Buy |
16,906
+1,738
| +11% | +$3.06K | ﹤0.01% | 5931 |
|
|
2024
Q2 | $219K | Sell |
15,168
-13,693
| -47% | -$198K | ﹤0.01% | 4484 |
|
|
2024
Q1 | $480K | Sell |
28,861
-3,049
| -10% | -$50.7K | ﹤0.01% | 4135 |
|
|
2023
Q4 | $512K | Buy |
31,910
+16,943
| +113% | +$272K | ﹤0.01% | 3952 |
|
|
2023
Q3 | $201K | Sell |
14,967
-299
| -2% | -$4.02K | ﹤0.01% | 4276 |
|
|
2023
Q2 | $262K | Buy |
15,266
+7,248
| +90% | +$125K | ﹤0.01% | 4274 |
|
|
2023
Q1 | $133K | Buy |
8,018
+6,326
| +374% | +$105K | ﹤0.01% | 4635 |
|
|
2022
Q4 | $28.3K | Buy |
1,692
+1,674
| +9,300% | +$28K | ﹤0.01% | 6125 |
|
|
2022
Q3 | $0 | Sell |
18
-553
| -97% | – | ﹤0.01% | 9402 |
|
|
2022
Q2 | $6K | Buy |
+571
| New | +$6K | ﹤0.01% | 7638 |
|